Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
J Dairy Sci ; 101(3): 2415-2422, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29290430

RESUMO

In this study, we aimed to evaluate the inhibitory effect of baicalin on Escherichia coli in vitro and the effects of baicalin treatment on antimicrobial resistance of the E. coli isolates. Through isolation, purification, and identification, a total of 56 E. coli strains were isolated from 341 mastitic milk samples. The study of inhibition effect of baicalin on the E. coli strains in vitro was focused on permeability and morphology of the isolates using an alkaline phosphatase kit and scanning electron microscopy. Furthermore, the resistance spectrum of the isolates to the common antimicrobial agents was tested at sub-minimum inhibitory concentrations of baicalin by the agar dilution method. Extended-spectrum ß-lactamase and plasmid-mediated quinolone resistance genes were amplified by PCR before and after incubation with baicalin. The results revealed that baicalin has certain inhibitory effects on the isolates in vitro. The alkaline phosphatase enzyme activity was significantly increased from 1.246 to 2.377 U/100 mL, and the surface of E. coli was concave and shriveled. Analysis of the resistance spectrum and PCR amplification showed that, after administration with baicalin, the sensitivity of most strains to the selected antimicrobial agents was enhanced. Strikingly, the drug-resistant genes from 71.43% (40/56) of these isolates were found to have drug-resistant genes to different extents. Altogether, the current study confirmed both the inhibitory effect on Escherichia coli in vitro and the reduction of antimicrobial resistance by baicalin. This is the first comprehensive study to report on baicalin, a traditional Chinese medicine that acts on E. coli isolated from the mastitic milk samples.


Assuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Flavonoides/farmacologia , Leite/microbiologia , Fosfatase Alcalina/metabolismo , Animais , Bovinos , Escherichia coli/enzimologia , Escherichia coli/isolamento & purificação , Infecções por Escherichia coli/microbiologia , Feminino , Mastite Bovina/microbiologia , Testes de Sensibilidade Microbiana , Plasmídeos , Quinolonas/farmacologia , beta-Lactamases/genética
2.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 17(1): 13-6, 1997 Jan.
Artigo em Chinês | MEDLINE | ID: mdl-9812643

RESUMO

OBJECTIVE: To assess the effect of Xianzhen tablet in treating non-insulin dependent diabetes mellitus (NIDDM). METHODS: Seventy-two cases of NIDDM patients with deficiency of both Qi and Yin, deficiency of the Kidney and blood stasis were selected, and the effects of treatment on Na(+)-K(+)-ATPase, Ca(2+)-Mg(2+)-ATPase, whole blood viscosity, blood sugar and clinical symptoms were observed. RESULTS: After treatment, the treated group showed increased activities that were statistically significant of Na(+)-K(+)-ATPase and Ca(2+)-Mg(2+)-ATPase (P < 0.01, P < 0.02). The whole blood viscosity and symptoms showed improvement to an extent and the total effective rate of blood sugar lowering were as follows: fasting blood glucose (FBG) 77.8%, 2hr. postprandial plasma blood glucose (2hr. postprandial PBG)69.4%. Whereas, the placebo group showed no marked improvement in either whole blood viscosity or symptoms and the total effective rate of blood sugar lowering were FBG 41.7%, 2hr. postprandial PBG 38.9%. CONCLUSION: Xianzhen tablet is effective in improving the activities of Na(+)-K(+)-ATPase and Ca(2+)-Mg(2+)-ATPase, as well as the whole blood viscosity, blood sugar lowering and in improving clinical symptoms, it could treat effectively NIDDM patients with deficiency of both Qi and Yin, deficiency of the Kidney and blood stasis.


Assuntos
ATPase de Ca(2+) e Mg(2+)/metabolismo , Diabetes Mellitus Tipo 2/enzimologia , Medicamentos de Ervas Chinesas/uso terapêutico , Membrana Eritrocítica/enzimologia , ATPase Trocadora de Sódio-Potássio/metabolismo , Adulto , Idoso , Glicemia/metabolismo , Viscosidade Sanguínea/efeitos dos fármacos , Estudos de Casos e Controles , Diabetes Mellitus Tipo 2/tratamento farmacológico , Combinação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Comprimidos , Deficiência da Energia Yin/tratamento farmacológico
3.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 16(1): 29-31, 1996 Jan.
Artigo em Chinês | MEDLINE | ID: mdl-8732128

RESUMO

Activity of erythrocyte superoxide dismutase (RBC-SOD), levels of serum malondialdehyde (MDA), plasma 6-keto-prostaglandin F 1 alpha (6-keto-PGF 1 alpha) and thromboxane B2(TXB2) were measured in 30 healthy subjects and 57 coronary heart desease (CHD) patients inoluding 21 cases complicated with diabetes and 36 without. Their characteristics of Syndrome Differentiation and typing were observed. The results showed that the activity of RBC-SOD, 6-keto-PGF 1 alpha in CHD patients were significantly lower than those in the healthy subjects, but the levels of TXB2, MDA were significantly higher. The levels of TXB2 in CHD patients with diabetes were significantly higher than tose without, but the activity of RBC-SOD were significantly lower. There were remarkably positive correlations between the levels of serum MDA and that of blood sugar, TXB2, TG and BMI in CHD patients with diabetes. There were remarkably negative correlations between the levels of serum MDA and plasma 6-keto-PGF 1 alpha. The results suggested that the metabolic abnormality of lipoperoxides was more serious in CHD patients with diabetes than without. The main Syndrome of CHD with diabetes was Qi-Yin Deficiency with Blood Stasis, while that of without diabetes was Qi Deficiency with Blood Stasis.


Assuntos
Doença das Coronárias/sangue , Diabetes Mellitus Tipo 2/sangue , Diagnóstico Diferencial , Peróxidos Lipídicos/sangue , Medicina Tradicional Chinesa , 6-Cetoprostaglandina F1 alfa/sangue , Pressão Sanguínea , Doença das Coronárias/complicações , Diabetes Mellitus Tipo 2/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Superóxido Dismutase/sangue , Tromboxano B2/sangue , Deficiência da Energia Yin/sangue
4.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 14(3): 139-41, 131, 1994 Mar.
Artigo em Chinês | MEDLINE | ID: mdl-7950179

RESUMO

62 cases of hyperlipemic patients were divided into 2 groups, 31 treated with Chinese herbal medicine Jiangzhi Zhongyao Pian (JZZYP) and the control group (31 cases) treated with placebo. Serum lipid, RBC-superoxide dismutase (RBC-SOD), and MDA were observed before and after 2 months treatment. Result showed that total cholesterol (TC), triglyceride (TG), atherogenic index (AI) and malondialdehyde (MDA) of test group were apparently dropped and high density lipid-cholesterol (HDL-C), RBC-SOD activity obviously elevated after treatment, the difference between two groups was significant (P < 0.05-0.001). The total effective rate of JZZYP on TC was 68.8%, that on TG was 86.7%. The results suggested that JZZYP has the effect of serum lipid regulation, antioxidase activity elevation and lipid peroxide inhibition. JZZYP had no side effect.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Hiperlipidemias/tratamento farmacológico , Hipolipemiantes/uso terapêutico , Adulto , Estudos de Casos e Controles , Colesterol/sangue , HDL-Colesterol/sangue , Método Duplo-Cego , Feminino , Humanos , Hiperlipidemias/sangue , Masculino , Malondialdeído/sangue , Pessoa de Meia-Idade , Superóxido Dismutase/sangue , Triglicerídeos/sangue
5.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 13(10): 587-90, 579, 1993 Oct.
Artigo em Chinês | MEDLINE | ID: mdl-8312692

RESUMO

The purpose of this study was to verify the effect of Jin-Qi-Jiang-Tang-Pian (JQJTP) on fasting blood glucose (FBG), postcibal blood glucose (PBG), total cholesterol (TC), triglycerides (TG), acetylcholine esterase (AchE), insulin, RBC-superoxide dismutase (RBC-SOD) and malondialdehyde (MDA). Efficacy was observed in 40 cases of diabetes mellitus, 20 cases administered with Yu-Quan Pian (YQP) were taken as control. Each group took drugs for two months. After treatment with Jin-Pi-Jiang-Tang-Pian, FBG, PBG, AchE were apparently dropped and RBC-SOD increased, as compared with patients of the YQP group (P < 0.05-0.01), and major symptoms of diabetes were improved. In experimental study, model rats suffering from diabetes induced by alloxan were observed, the rats' blood sugar level above 11.1 mmol/L were chosen for observation. These rats were divided into JQJTP group, YQP group and control group. It was found that JQJTP was able to lower blood sugar, TG and MDA (P < 0.05-0.001) significantly, with a increase of the SOD/MDA, as compared with those of patients of the control groups.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Medicamentos de Ervas Chinesas/uso terapêutico , Hipoglicemiantes/uso terapêutico , Idoso , Animais , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 2/sangue , Feminino , Humanos , Masculino , Malondialdeído/sangue , Camundongos , Pessoa de Meia-Idade , Ratos , Ratos Wistar , Superóxido Dismutase/sangue , Comprimidos
7.
Zhong Xi Yi Jie He Za Zhi ; 11(1): 20-2, 4, 1991 Jan.
Artigo em Chinês | MEDLINE | ID: mdl-2054886

RESUMO

The purpose of this study was to verify the effect of a Chinese herbal medicine Jiang-Zhi Zhong-Yao-Pian to reduce serum lipoid. Efficacy was observed in 30 cases of hyperlipemia; 20 cases administered with evening primose oil capsules were taken as controls. Each group took drugs for two or three months. The results were as follows: After treatment as compared with before treatment, the serum levels of TC, TG and TXB2 dropped from 264.28 +/- 70.52 mg%, 393.52 +/- 250.42 mg% and 110.75 +/- 43.52 pg/ml to 225.60 +/- 50.93 mg%, 264.97 +/- 252.81 mg% and 88.82 +/- 46.50 pg/ml respectively (P less than 0.001, less than 0.01, less than 0.05). However, in the group taking evening primrose oil capsules, TC, TG and TXB2 in comparing with the pre-treatment levels were changed from 251.33 +/- 58.24 mg%, 316.35 +/- 104.93 mg% and 131.53 +/- 49.77 pg/ml to 244.30 +/- 43.28 mg%, 272.10 +/- 92.52 mg% and 115.33 +/- 47.49 pg/ml respectively (P greater than 0.05, less than 0.05, greater than 0.05). This medicine had no side-effect. The results showed that the herbal formula might be useful to reduce serum TC, TG and TXB2.


Assuntos
6-Cetoprostaglandina F1 alfa/sangue , Colesterol/sangue , Medicamentos de Ervas Chinesas/uso terapêutico , Hiperlipidemias/tratamento farmacológico , Hipolipemiantes , Tromboxano B2/sangue , Triglicerídeos/sangue , Feminino , Humanos , Hiperlipidemias/sangue , Masculino , Pessoa de Meia-Idade , Comprimidos
10.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 11(2): 87-91, 1989 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-2528425

RESUMO

Hemorrheologic tests were studied in 68 cases of diabetes with symptoms of deficiency of both Qi and Yin and blood stasis. The results showed that whole blood viscosity, plasma viscosity, hematocrit and RBC filterability in diabetics were significantly higher than in normal controls, except for hematocrit in male patients. After treatment with "Yiqi Yangyin Huoxue" prescription by Prof. Zhu Shenyu, whole blood viscosity (at shear rates of 3.83 s-1, 38.3 s-1, 192 s-1), plasma viscosity, hematocrit and RBC filterability were apparently improved, with a decrease of fasting blood sugar, as compared with patients of the placebo group.


Assuntos
Viscosidade Sanguínea/efeitos dos fármacos , Diabetes Mellitus Tipo 2/sangue , Medicamentos de Ervas Chinesas/uso terapêutico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Deformação Eritrocítica/efeitos dos fármacos , Feminino , Hematócrito , Humanos , Masculino , Pessoa de Meia-Idade , Reologia
11.
Artigo em Inglês | MEDLINE | ID: mdl-2594735

RESUMO

There was a statistically significant increase in whole blood viscosity, plasma viscosity, erythrocyte filterability index and hematocrit in diabetics with "Qi Yin deficiency and blood stasis" syndrome. After treatment with "Yi Qi Yang Yin Hou Xue" prescription there was a statistically significant improvement in hemorheological properties and a slight decrease in fasting blood glucose.


Assuntos
Viscosidade Sanguínea/efeitos dos fármacos , Diabetes Mellitus Tipo 2/sangue , Medicamentos de Ervas Chinesas/uso terapêutico , Adulto , Diabetes Mellitus Tipo 2/tratamento farmacológico , Deformação Eritrocítica/efeitos dos fármacos , Feminino , Fibrinogênio/metabolismo , Hematócrito , Humanos , Masculino , Medicina Tradicional Chinesa , Pessoa de Meia-Idade , Reologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA